Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0071 | 0.7639 | 1 | |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0091 | 1 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0091 | 1 | 1 |
Schistosoma mansoni | jun-related protein | 0.0074 | 0.7941 | 1 |
Echinococcus granulosus | jun protein | 0.0091 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0074 | 0.7941 | 1 |
Brugia malayi | hypothetical protein | 0.0071 | 0.7639 | 0.7639 |
Echinococcus multilocularis | jun protein | 0.0091 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0088 | 0.9699 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 380 uM | Ability to inhibit autophosphorylation of KinA and/or Sp0F TCS proteins from Bacillus subtilis | ChEMBL. | 10571153 |
IC50 (functional) | > 500 uM | Ability to inhibit autophosphorylation of NR11 and/or transphosphorylation of NR1 TCS proteins from E. coli | ChEMBL. | 10571153 |
IC50 (functional) | > 500 uM | Ability to inhibit autophosphorylation of NR11 and/or transphosphorylation of NR1 TCS proteins from E. coli | ChEMBL. | 10571153 |
MIC (functional) | = 64 ug ml-1 | In vitro antibacterial activity against against Staphylococcus aureus strain, ATCC29213 | ChEMBL. | 10571153 |
MIC (functional) | = 64 ug ml-1 | In vitro antibacterial activity against against methicillin resistant Staphylococcus aureus (MRSA) strain, OC2089 | ChEMBL. | 10571153 |
MIC (functional) | = 128 ug ml-1 | In vitro antibacterial activity against against E. faecalis strain, OC3041 | ChEMBL. | 10571153 |
MIC (functional) | = 128 ug ml-1 | In vitro antibacterial activity against against E. faecium(VR) strain, OC3312 Van R | ChEMBL. | 10571153 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.